| Current Role of Pharmacogenomics in Cardiovascular Medicine. | |
| | |
MedLine Citation:
|
PMID: 21537956 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OPINION STATEMENT: Pharmacogenomics holds the promise of transforming patient care by allowing providers to tailor therapy to each individual patient based on his or her genetic information. Although no established pharmacogenomic applications in cardiovascular medicine yet exist, there are at least three emerging applications that may ultimately become routine clinical practice; these are related to warfarin, clopidogrel, and statins. Of the three, warfarin pharmacogenomics has been the most rigorously evaluated to date, with several clinical trials either completed or underway. Clopidogrel pharmacogenomics has a growing body of supporting scientific evidence and warrants evaluation in prospective clinical trials. Statin pharmacogenomics remains the least developed application, with controversy surrounding a widely marketed genetic test whose validity has been questioned by recent evidence. Providers are advised to take a "wait and see" approach to pharmacogenomics at the present time, with the expectation that it will be a few years before any cardiovascular pharmacogenomic application is unequivocally proven to be both cost-effective as well as of clinical benefit. |
| | |
Authors:
|
Kiran Musunuru |
Related Documents
:
|
20444056 - Establishing a distributed campus: making sense of disruptions to a doctor community. 19575076 - Education in skin cancer management--assessing knowledge and safety. 11650696 - The employment physical examination: what is the doctor's obligation of confidentiality? 12497736 - Euthanasia: why it doesn't matter (much) what the doctor thinks and why there is no sug... 20819846 - End-of-life practices in palliative care: a cross sectional survey of physician members... 15013206 - Ethnobotanical studies on medicinal plants used by the red-headed yao people in jinping... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-5-3 |
Journal Detail:
|
Title: Current treatment options in cardiovascular medicine Volume: - ISSN: 1534-3189 ISO Abbreviation: - Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-5-3 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9815942 Medline TA: Curr Treat Options Cardiovasc Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Center for Human Genetic Research, Cardiovascular Research Center, Massachusetts General Hospital, 185 Cambridge St CPZN 5th floor, Boston, MA, USA, kmusunuru@partners.org. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput ...
Next Document: Molecular dynamics simulation and density functional theory studies on the active pocket for the bin...